2018
DOI: 10.1016/j.molmed.2017.11.006
|View full text |Cite
|
Sign up to set email alerts
|

Targeting the 26S Proteasome To Protect Against Proteotoxic Diseases

Abstract: Aggregates of misfolded proteins can compromise the function of the 26S proteasome complex, leaving neurons susceptible to accelerated and impaired protein homeostasis, thereby contributing to the pathogenesis of neurodegeneration. Strategies aimed at enhancing the function of the 26S proteasome via phosphorylation of key subunit epitopes have been effective in reducing protein aggregates in mouse models of disease. We discuss how phosphodiesterase (PDE) inhibitors and G protein-coupled receptor (GPCR)-targete… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
42
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(42 citation statements)
references
References 102 publications
0
42
0
Order By: Relevance
“…The transcriptional/translational ER stress responses [ 42 ], as well as the pathways delivering misfolded polypeptides from the ER to the cytosol for degradation by the ubiquitin proteasome system [ 43 ], have been elucidated in molecular details. Pharmacologic modulation of the UPR [ 44 46 ] and the ubiquitin proteasome system [ 47 ] are expected to affect on protein misfolding diseases, cognitive disorders and tumors to mention just a few pathologic states resulting from proteostasis impairment. In sharp contrast, only recently the characterization of the molecular mechanisms ensuring lysosomal clearance of ER fragments or subdomains has attracted the interest of cell biologists.…”
Section: Discussionmentioning
confidence: 99%
“…The transcriptional/translational ER stress responses [ 42 ], as well as the pathways delivering misfolded polypeptides from the ER to the cytosol for degradation by the ubiquitin proteasome system [ 43 ], have been elucidated in molecular details. Pharmacologic modulation of the UPR [ 44 46 ] and the ubiquitin proteasome system [ 47 ] are expected to affect on protein misfolding diseases, cognitive disorders and tumors to mention just a few pathologic states resulting from proteostasis impairment. In sharp contrast, only recently the characterization of the molecular mechanisms ensuring lysosomal clearance of ER fragments or subdomains has attracted the interest of cell biologists.…”
Section: Discussionmentioning
confidence: 99%
“…Dysregulations of the UP characterize a variety of neurological disorders where immune alterations occur, such Multiple Sclerosis (MS) and neuro-infectious diseases, but also classic neurodegenerative disorders such as Parkinson's, Alzheimer's, and Huntingtin's diseases (PD, AD, HD), epilepsy, brain stroke, and drug abuse (3342). As such, the contribute of UP in the context of inflammatory- and immune-related biology of CNS disorders has been increasingly investigated (43, 44). The present mini-review analyzes those UP-related molecular mechanisms underpinning the shift from baseline neuro-immune surveillance to inflammatory and auto-immune neuropathology.…”
Section: Introductionmentioning
confidence: 99%
“…Proteasome inhibitors including bortezomib and carfilzomib have been used therapeutically for treatment of multiple myeloma and mantle cell lymphoma in patients (Kisselev et al, 2012; Teicher and Tomaszewski, 2015). In contrast, several drugs that increase 26S proteasome activity have potential applications in the treatment of neurodegenerative diseases (Myeku and Duff, 2018).…”
Section: Overview Of Human Proteasomementioning
confidence: 99%